Clinical Trials on Intubated Requiring Sedation for Greater Than 48 Hours in South Africa
Total 0 results
Nothing found
Sponsors and Collaborators
- Carlos R. Cervantes Sanchez
- Wujin people hospital of Changzhou city
- Ministry of Health, Mexico City
- Dalian University Affiliated Xinhua Hospital
- Koronis Biomedical Technologies
- HNEC TEST
- The 1st affiliated hospital of Jinzhou Medicine University
- ARTBIO Inc.
- Daehwa Pharmaceutical Co., Ltd.
- Zidong Campus of Jiangsu Provincial Hospital of TCM
- UHZ Sports Medicine Institute
- University of Regensburg, Tumor Center Regensburg, Center for Quality Management and Health Services Research
- Swim Across America Foundation
- Zhuhai Tonbridge Medical Tech. Co., Ltd.
- Eosera Inc
- Dr. Dirk Bastian
- Giorgio Quadri
- Giovanni Barisione "Unità Operativa di Medicina Preventiva e del Lavoro, Laboratorio di Fisiopatologia Respiratoria", S. Martino Hospital, Genoa, Italy
- Heart and Stroke Foundation of Canada - Canadian Partnership for Stroke Recovery
- KRJG Services Inc.
- View Full List
Medical Conditions
- Cerebellar Ataxia and Hypogonadotropic Hypogonadism
- Laparoscopic Myomectomy
- Mood and Cognitive Performance
- General Anesthetic
- ROS1 Rearrangement Non-small Cell Lung Cancer
- Adenocarcinoma, Bronchiolo-Alveolar
- Infectious Risk
- Vaginal Discharge
- Respiratory Distress Syndrome of Newborn
- Adult Glioma
- Recurrent Metastases
- Hib Diseases
- Genito-Pelvic Pain
- Plasmodium Infection
- Gastroesophageal Junction Adenocarcinoma
- Seborrheic Keratosis (SK)
- Late Mild Cognitive Impairment (LMCI)
- Perforation of the Oesophagus
- Ureter Urothelial Carcinoma
- Rheumatoid Arthritis, NOS
- View Full List
Drug Interventions
- HTX-011B
- SK-0403
- Acthar Injectable Product
- Ivonescimab (SMT112 or AK112) Injection
- Part 1: Lotion
- Cisplatin (DDP)
- Romosozumab
- Color-matched vehicle containing 0 mg of JNJ 10229570-AAA
- Bevacizumab
- Esomeprazole 20mg
- Sterimar Spray
- Sorafenib
- PH-797804
- Sotrovimab
- Low-dose ticagrelor
- Verapamil
- CB-NK-TGF-βR2-/NR3C1
- MN-08 60 mg/day
- Cohort 1
- Moxifloxacin
- View Full List
CROs by country
- Contract Research Organizations in Bulgaria
- Contract Research Organizations in Canada
- Contract Research Organizations in Finland
- Contract Research Organizations in Japan
- Contract Research Organizations in Lithuania
- Contract Research Organizations in Mali
- Contract Research Organizations in Montenegro
- Contract Research Organizations in Pakistan
- Contract Research Organizations in Paraguay
- Contract Research Organizations in Russia
- Contract Research Organizations in Senegal
- Contract Research Organizations in Ukraine
- Contract Research Organizations in Zambia
- CRO list by country